Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Glaxosmithkline Plc LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  24.80 1.8% 1,405.00 1,406.20 1,407.00 1,416.00 1,385.40 1,390.00 6,483,102 16:35:03
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 33,754.0 6,221.0 93.9 15.0 70,671

Glaxosmithkline Share Discussion Threads

Showing 19301 to 19322 of 23800 messages
Chat Pages: Latest  784  783  782  781  780  779  778  777  776  775  774  773  Older
DateSubjectAuthorDiscuss
01/3/2019
08:20
https://www.theguardian.com/breakthrough-science/2019/feb/28/will-genetics-unlock-a-new-treatment-for-parkinsons
tradermichael
01/3/2019
07:06
Read my post.
montyhedge
28/2/2019
20:00
Lol ..according to you we should have been down here this week ..haven't seen it YET!I'm actually agreeing with Zico ..plucking numbers out of ....
badtime
28/2/2019
15:28
My tip is to get on board with GSK while you can at these lowly levels. There are a lot of products in the pipeline and they have engineered some valuable alliances and takeovers. Their true value has not been recognised by the market yet (particularly the impact of stripping off the Consumer healthcare Group, which could happen a lot sooner than projected). Any short-term shortfall in the price you pay will be more than compensated by the dividend (which by the way is safe).
tradermichael
28/2/2019
15:23
grahamite I think i called this right, lol.
montyhedge
28/2/2019
15:13
Taylor Wimpey. I cleaned up on it when its price collapsed for no reason after the referendum result. A similar gain was available for those who bought in December.
grahamite2
28/2/2019
13:36
Good luck nimbo1. It took me 4 years to get out of this unscathed and I'm not getting back in except at a price I can be fairly sure I'll not be looking at a red number for another 4 years. The next 4 weeks will no doubt be pretty choppy and should give some decent entry points. That said I missed the bus totally on TW. so what do I know.
grahamite2
28/2/2019
10:58
Im buying more - this seems far more resilient than one might have expected given forex headwinds - the beginnings of a shift in sentiment towards Gsk i hope.
nimbo1
28/2/2019
10:33
I like 1465 Monty. There is an implicit suggestion that your number is more scientific than 1450. Let's be honest here. Both numbers have been plucked out of our backsides. If dollar strengthens, GSK falls and this fall is exacerbated by the poor dividend cover.
zicopele
28/2/2019
08:31
Pound will get stronger 70% of FTSE 100 dollar earners.
montyhedge
28/2/2019
08:25
I think 1465p.
montyhedge
27/2/2019
18:26
@Zico, GSK back at 1450p would be very interesting once again.
wbecki
27/2/2019
15:08
Could see GSK falling to 14.50
zicopele
27/2/2019
15:07
Ess Yes if thats happens GSK 1465p
montyhedge
27/2/2019
14:51
Mentioned a few times I thought there was significant upside to GBP against USD/EURO as leaving Without a deal was unlikely. That now looks underway. Would not surprise me to see GBP/EURO at 1.25 plus, and would not rule at comfortably over 1.30 in time. 1.37/8 area on cable.
essentialinvestor
27/2/2019
12:06
what a dog this share is, bring back the old management.
porsche1945
26/2/2019
17:43
Pound two year high, FTSE 100, 70% of companies are dollar earners.
montyhedge
26/2/2019
13:33
Could be heading to test 1480p, although a strengthening £ could see the share price heading lower, to test the next support area 1430p
ny boy
26/2/2019
11:43
Disagree. GSK is a short term currency play. Mathematics. (Of course there are business factors too).
alphorn
26/2/2019
11:38
Rock star - whether "you" believe in Brexit is irrelevant. It's the old saying, it's not what you think, it's what you think other people think.
grahamite2
26/2/2019
11:34
"U.S. healthcare stocks may face some turbulence today as leaders from the largest pharmaceutical companies get grilled on Capitol Hill over the high cost of prescription drugs" The congressional hearing, called "Drug Pricing in America: A Prescription for Change, Part II," is reminiscent of previous encounters with businesses that proved to be turning points, leading to massive reforms on Wall Street, the health insurance industry and tobacco companies.
wbecki
26/2/2019
10:15
Dollars earners are about 70% of the FTSE 100 on some kind of Brexit deal, markets falls 10% on no deal market up 10%. I say down on a deal.
montyhedge
Chat Pages: Latest  784  783  782  781  780  779  778  777  776  775  774  773  Older
ADVFN Advertorial
Your Recent History
LSE
GSK
Glaxosmith..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210126 05:21:56